Global Blood Therapeutics announces closing of public offering of common stock
Global Blood Therapeutics announced the closing of its previously announced underwritten public offering of 6,400,000 shares of common stock, at the public offering price of $18.75 per share. GBT estimates net proceeds from will be $112.3 million. June 24, 2016